489 episodes

The T1D news show you've been waiting for! Long-time broadcaster, blogger and diabetes mom Stacey Simms interviews prominent advocates, authors and speakers. Stacey asks hard questions of healthcare companies and tech developers and brings on "everyday' people living with type 1. Great for parents of T1D kids, adults with type 1 and anyone who loves a person with diabetes.

Diabetes Connections with Stacey Simms Type 1 Diabetes Stacey Simms

    • Health & Fitness
    • 4.7 • 169 Ratings

The T1D news show you've been waiting for! Long-time broadcaster, blogger and diabetes mom Stacey Simms interviews prominent advocates, authors and speakers. Stacey asks hard questions of healthcare companies and tech developers and brings on "everyday' people living with type 1. Great for parents of T1D kids, adults with type 1 and anyone who loves a person with diabetes.

    In the News... Insulin pricing bill, Nasal insulin tested, Light at night as a T2D risk, and more!

    In the News... Insulin pricing bill, Nasal insulin tested, Light at night as a T2D risk, and more!

    It’s “In the News..” got a few minutes? Get caught up! Top stories this week: The US Senate may have a bipartisan plan to lower the price of insulin for the insured, nasal insulin is tested to reduce the risk of Alzheimer's in people with diabetes, two interesting studies about sleep and diabetes, and more!
    Check out Stacey's book: The World's Worst Diabetes Mom!
    Join the Diabetes Connections Facebook Group!
    Sign up for our newsletter here
    -----
    Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
    -----
    Episode Transcription Below (or coming soon!)
    Please visit our Sponsors & Partners - they help make the show possible!
    *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.
    XX
    In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population.
    https://t1dexchange.org/stacey/
    XX
    Two Senators have unveiled legislation aimed at lowering the cost of insulin, but not for the uninsured. This is a bipartisan bill that would lower patietn’s cost to 35-dollars a month, for those with commercial insurance and on Medicare. It would eliminate the rebates drug companies pay to negotiators known as pharmacy benefit managers if the drug company kept the overall price of insulin below a certain level. Democrats are also in the midst of talks on a party-line package on President Biden’s economic agenda that would likely include reductions in insulin costs as well as broader measures aimed at lowering drug prices, which could complicate any push for a stand-alone insulin measure. This change has enormous support among Americans, but can’t seem to get any real traction in Washington despite who’s in power. We’ll see what happens..
    https://thehill.com/policy/healthcare/3531954-bipartisan-pair-of-senators-unveils-bill-to-lower-insulin-costs/
    XX
    Nasal insulin doesn’t look like it works too well on diabetes, but a new study shows it may help to slow age related mental decline. This study found that after 12 months of once daily intranasal insulin, people with diabetes in the study performed better on cognitive tests than those diabetics in the placebo group. The non-diabetic group receiving the intranasal insulin also displayed improvements on decision making and verbal memory tests compared to non-diabetics in the placebo group.
    The biggest improvements in the non-diabetic group were seen in those subjects who started the trial in a prediabetic state. This suggests the treatment may be most effective at slowing cognitive decline in either diabetics or those with prediabetes.
    https://newatlas.com/health-wellbeing/insulin-nasal-spray-cognitive-decline-dementia-clinical-trial/
    XX
    Go to sleep, and don’t breathe too much. Researchers in the U.K. will test hypoxia to treat type 2 diabetes. Hypoxia is a state where the body does not receive sufficient amounts of oxygen.
    Multiple studies have shown that hypoxia improves blood sugar levels and aids in weight loss. Although scientists do not fully understand how this works, it is suggested that hypoxia burns more calories in the body, resulting in lower appetites in individuals. These researchers want to recruit volunteers so they can figure out why. Each volunteer will be provided with a sleeping tent in which they have to sleep – at home - for 10-day periods on two separate occasions. For one of they nights, they oxygen levels will be set to 15 percent. That sounds ridiculous, but, the air we breathe right now is only about 21% oxygen. 15-percent is pretty typical for find at high altitudes or inside an airplane.
    https://interestingengineering.com/lose-weight-while-asleep
    XX
    Another look at sleepin

    • 6 min
    "Stay Connected, With Style" Meet Erin Calhoun-Dulaney of Skirt My Pump

    "Stay Connected, With Style" Meet Erin Calhoun-Dulaney of Skirt My Pump

    Wearing an insulin pump can be a huge help when it comes to managing diabetes, but finding a place to put it can be difficult. Women’s clothing in particular, isn’t great for storing stuff. Erin Calhoun-Dulaney has lived with type 1 for 40 years and she finally got fed up enough to create her own product. We’ll talk about Skirt my Pump, her experience with T1D and her career as a Hollywood publicist.
    Stacey also has information about Tandem's Mobile Bolus limited roll out. Click here to find out more and sign up. 
    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
    Check out Stacey's book: The World's Worst Diabetes Mom!
    Join the Diabetes Connections Facebook Group!
    Sign up for our newsletter here
    -----
    Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
    -----
    Episode Transcription Below (or coming soon!)
    Please visit our Sponsors & Partners - they help make the show possible!
    *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM*

    • 39 min
    In the News... Tandem Mobile Bolus, long-acting insulin study, new hospital guidelines for diabetes & more!

    In the News... Tandem Mobile Bolus, long-acting insulin study, new hospital guidelines for diabetes & more!

    It’s “In the News..” got a few minutes? Get caught up! Top stories this week: Tandem Diabetes announces a limited launch of their mobile bolus feature (signup below), researchers look at how Basaglar stacks up, new guidelines for diabetes in the hospital, a T1D extreme athlete bikes across the USA and more
    Learn about the T1D Exchange!
    Check out Stacey's book: The World's Worst Diabetes Mom!
    Join the Diabetes Connections Facebook Group!
    Sign up for our newsletter here
    -----
    Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
    -----
    Episode Transcription Below (or coming soon!)
    Please visit our Sponsors & Partners - they help make the show possible!
    *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. we go live on social media first and then All sources linked up at diabetes dash connections dot com when this airs as a podcast.
    XX
    In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population.
    https://t1dexchange.org/stacey/
    XX
    Tandem’s mobile bolus feature is in limited release. Approved earlier this year, they’ve released the feature to a very small number of users and are expecting a wider, still limited, release in the next few weeks. This is the feature that allows you to bolus by phone and use the t-connect app to see pump data on your phone as well. It’s not full pump control via phone, but it’s a big step forward in terms of convenience for users and for Tandem’ next product, the MOBI pump – which won’t have a screen and will have full phone control. I’m asking Tandem to come on the show and share more about the features and how it works. It’s interesting that you can’t dismiss alerts and alarms from the app and must do so on the pump itself. I’ll link up the site you need to sign up for the limited release. You will need to update the software on your tslim x2 pump and take some additional online training. This is US only.
    https://www.tandemdiabetes.com/landing-pages/remote-bolus
    XX
    The Eversense E3 gets European approval. This is a partnership between Ascensia diabetes care and Senseonics. The E3 is the six month version of the implantable CGM system. It’s also approved for insulin treatment decisions, which is a switch from the XL version already available in Europe. The E3 was approved in the US earlier this year and should be distributed in Europe in the fall.
    https://finance.yahoo.com/news/ascensia-diabetes-care-announces-european-060000125.html
    XX
    XX
    New guidelines for treating diabetes in the hospital. This is from the Endocrine Society, which last updated their guidelines ten years ago. New this time around, hospital use of continuous glucose monitoring and insulin pump therapy, providing inpatient diabetes education as part of a comprehensive diabetes discharge-planning process, use of noninsulin glucose-lowering therapies, and more.
    Adult patients with diabetes or newly recognized hyperglycemia account for greater than 30% of noncritically ill hospitalized patients.
    https://www.clinicaladvisor.com/home/topics/endocrinology-information-center/endocrine-society-issues-new-guidelines-for-hospitalized-patients-with-diabetes/
    XX
    Works just as well and costs less.. that’s the upshot of a new study on Basaglar, the copycat insulin to Lantus when it comes to type 2 diabetes. The findings come from 14 commercial health plans and Medicare Advantage plans. Basaglar was approved as a biosimilar insulin glargine by the US Food and Drug Administration in 2015. This was a large study of thousands of patients and also showed that there was better adherence to Basaglar, no reason for that was given, b

    • 5 min
    "This is Becoming a Reality" - Sernova's Cell Therapy Approach to a Functional T1D Cure

    "This is Becoming a Reality" - Sernova's Cell Therapy Approach to a Functional T1D Cure

    Big news from Sernova, one of the companies hoping that implantable stem cells will be a functional cure for diabetes. They recently announced that the first person in their trials with type 1 is completely off injected or infused insulin – and is making their own.
    Stacey talks to Dr. Philip Toleikis, Sernova’s president and CEO. He explains how their process differs from some of the other companies looking at stem cells, talks about their partnerships and shares more about the patients doing well in this clinical trial.
    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
    Check out Stacey's book: The World's Worst Diabetes Mom!
    Join the Diabetes Connections Facebook Group!
    Sign up for our newsletter here
    -----
    Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
    -----
    Episode Transcription Below (or coming soon!)
    Please visit our Sponsors & Partners - they help make the show possible!
    *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM*

    • 43 min
    In the News... Pharmacy middle-men investigated, stem cell update, once-a-week basal insulin and more!

    In the News... Pharmacy middle-men investigated, stem cell update, once-a-week basal insulin and more!

    It's "In the News.." got a few minutes? Get caught up! Top stories this week: The Federal Trade Commission probes the prescription drug middleman industry, once a week basal insulin moves forward, DIY insuln dosing systems get a thumbs up at ADA Scientific Sessions, Sernova's stem cell system releases great findings and more!
    Learn more about the T1D Exchange
    Check out Stacey's book: The World's Worst Diabetes Mom!
    Join the Diabetes Connections Facebook Group!
    Sign up for our newsletter here
    -----
    Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
    -----
    Episode Transcription Below (or coming soon!)
    Please visit our Sponsors & Partners - they help make the show possible!
    *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days. we go live on social media first and then All sources linked up at diabetes dash connections dot com when this airs as a podcast.
    XX
    In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population.
    https://t1dexchange.org/stacey/
    XX
    The Federal Trade Commission will launch an inquiry into the prescription drug middleman industry.. requiring the six largest pharmacy benefit managers to provide information and records. They’re looking at PBMs such as CVS Caremark; Express Scripts, Inc.; OptumRx, Inc.; Humana Inc and more. The largest PBMs are now vertically integrated with the largest health insurance companies and wholly owned mail order and specialty pharmacies. In these roles, pharmacy benefit managers often have enormous influence on which drugs are prescribed to patients, which pharmacies patients can use, and how much patients ultimately pay at the pharmacy counter.
    https://www.ftc.gov/news-events/news/press-releases/2022/06/ftc-launches-inquiry-prescription-drug-middlemen-industry?utm_campaign=https://www.ftc.gov/news-&utm_content=1654622484&utm_medium=social&utm_source=twitter
    XX
    Confirming what many of you have known for years.. an open-source automated insulin delivery system -- also known as a do-it-yourself system -- was both safe and effective for patients with type 1 diabetes. This is from the CREATE trial, designed to test DIY system, presented for the first time at the ADA Scientific Sessions. This system was made up of the OpenAPS algorithm from a version of AndroidAPS implemented in a smartphone, paired with the DANA-i insulin pump and Dexcom G6 continuous glucose monitor. The researchers previously published additional information in the Journal of Diabetes & Metabolic Disorders.
    https://www.medpagetoday.com/meetingcoverage/ada/99109
    XX
    Stem cell study showing great results. Sernova says the first three patients of six total continue to be insulin independent following treatment. One of the patients has been insulin-free for more than two years, while the other two have been free of the need for medication injections for six months and three months, respectively. At this point, the other three patients in the study have not had the device long enough to determine measurable results. The first three all have A1Cs in a normal, nondiabetic range.
    Sernova's Cell Pouch is an implantable device that releases the primary donor islets. The device is implanted under the skin in a minimally-invasive procedure. We’re talking to Sernova for next week’s show; long way to go here but another good result for stem cells.
    https://www.biospace.com/article/sernova-cell-pouch-device-keeps-type-1-diabetes-patient-insulin-free-for-two-years/
    XX
    Getting closer to once-a-week basal insulin. New study says Novo Nordisk insulin icodec achieved better results than Lantus in some aspects of the study and that overall it w

    • 5 min
    "Dexcom is Preparing for the Future" CEO Kevin Sayer on G7, the international market, competitors and more

    "Dexcom is Preparing for the Future" CEO Kevin Sayer on G7, the international market, competitors and more

    Dexcom CEO Kevin Sayer joins Stacey from the American Diabetes Association’s Scientific Sessions with new G7 information, a response to Abbott’s Libre 3 approval, addressing rumors about acquiring another diabetes company and a lot more.
    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.
    Check out Stacey's book: The World's Worst Diabetes Mom!
    Join the Diabetes Connections Facebook Group!
    Sign up for our newsletter here
    -----
    Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
    -----
    Episode Transcription Below (or coming soon!)
    Please visit our Sponsors & Partners - they help make the show possible!
    *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM*

    • 32 min

Customer Reviews

4.7 out of 5
169 Ratings

169 Ratings

GoletaMom ,

Great content!

I love the range of information Stacy shares and the variety of quests. She produces a very professional podcast on diabetes!

Reymaestro ,

An essential for anyone affected by T1D

My son was diagnosed in the middle of the pandemic, resources and connections in person were limited to none. This podcast was an incredible resource in figuring out his care. We decided to go for Tandem’s brand new CIQ at 3 months after diagnosis on 2021. His A1Cs have been in the 5s ever since. I really thank the podcast for helping us make the best decision possible for our son. I love staying on top of what’s new with TD1 technology and I will forever be grateful. Thank you Stacy!!!!

FloraDora5753 ,

Stacy Simm’s does a wonderful job advocating for folks with Diabetes

Stacy’s shows are entertaining, informative and timely. As technology is changing very quickly, she keeps people that want and need information, up to date on what is available for someone who needs insulin to live.

As a Mom of a person with T1 diabetes ,she has dedicated her life to educating others and with so many people living with Diabetes now, it’s a huge need to educate not only the person who has Diabetes but the General Medical Community and family members. On what’s needed to live a happy and healthy life while managing this disease.

The key to that is the technology and education. Stacy provides information on all that is involved.

Stacy has a great voice for doing Podcasts and it’s like having a friend in the room, when listening to her show.
Well done, Stacy Simms.

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Aubrey Gordon & Michael Hobbes
Lewis Howes
Dr. Mark Hyman
Slumber Studios

You Might Also Like

Scott Benner
Cyrus Khambatta, PhD & Robby Barbaro, MPH (both living with type 1 diabetes
FTF Warrior
Colleen Mitchell
Dr Rupy Aujla
Katie Roseborough